Legend Biotech Corp. (LEGN)
15.99
-1.51
(-8.63%)
USD |
NASDAQ |
Nov 16, 16:00
15.89
-0.10
(-0.63%)
After-Hours: 04:52
Legend Biotech Price to Book Value : 2.437 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 2.437 |
| November 13, 2026 | 2.667 |
| November 12, 2026 | 2.826 |
| November 11, 2026 | 2.978 |
| November 10, 2026 | 3.111 |
| November 09, 2026 | 3.702 |
| November 06, 2026 | 3.566 |
| November 05, 2026 | 3.435 |
| November 04, 2026 | 3.470 |
| November 03, 2026 | 3.274 |
| November 02, 2026 | 3.216 |
| October 30, 2026 | 3.297 |
| October 29, 2026 | 3.399 |
| October 28, 2026 | 3.434 |
| October 27, 2026 | 3.286 |
| October 26, 2026 | 3.108 |
| October 23, 2026 | 2.937 |
| October 22, 2026 | 2.881 |
| October 21, 2026 | 2.839 |
| October 20, 2026 | 2.897 |
| October 19, 2026 | 2.842 |
| October 16, 2026 | 2.817 |
| October 15, 2026 | 3.018 |
| October 14, 2026 | 2.902 |
| October 13, 2026 | 2.725 |
| Date | Value |
|---|---|
| October 12, 2026 | 2.713 |
| October 09, 2026 | 2.838 |
| October 08, 2026 | 2.852 |
| October 07, 2026 | 2.914 |
| October 06, 2026 | 2.853 |
| October 05, 2026 | 2.862 |
| October 02, 2026 | 2.830 |
| October 01, 2026 | 2.945 |
| September 30, 2026 | 3.032 |
| September 29, 2026 | 2.966 |
| September 28, 2026 | 2.934 |
| September 25, 2026 | 3.011 |
| September 24, 2026 | 3.004 |
| September 23, 2026 | 2.907 |
| September 22, 2026 | 2.937 |
| September 21, 2026 | 2.92 |
| September 18, 2026 | 2.775 |
| September 17, 2026 | 2.770 |
| September 16, 2026 | 2.679 |
| September 15, 2026 | 2.784 |
| September 14, 2026 | 2.92 |
| September 11, 2026 | 2.937 |
| September 10, 2026 | 3.024 |
| September 09, 2026 | 3.138 |
| September 08, 2026 | 3.229 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.95 |
| Ionis Pharmaceuticals, Inc. | 11.84 |
| Cellectar Biosciences, Inc. | 0.4523 |
| ACADIA Pharmaceuticals, Inc. | 2.325 |
| Alnylam Pharmaceuticals, Inc. | 5.934 |
Price to Book Value Related Metrics
| PS Ratio | 2.242 |
| Price | 15.99 |
| Earnings Yield | -0.19% |
| Market Cap | 3.102B |
| Operating PE Ratio | 80.45 |